National Institute of Pharmaceutical Education and Research Guwahati

What National Institute of Pharmaceutical Education and Research Guwahati does

NIPER Guwahati (National Institute of Pharmaceutical Education and Research Guwahati) is a government-owned autonomous institution declared an "Institute of National Importance" under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. Founded in September 2008, it is the fifth institute in the NIPER system and the only such national pharmaceutical education and research institute serving the entire North Eastern Region of India, with operations consolidated at its permanent Changsari campus in Guwahati, Assam since 2015. The institute delivers postgraduate and doctoral programmes (MS Pharm., M.Pharm, M.Tech in Medical Devices, and PhD) across eight academic departments - Pharmacology & Toxicology, Biotechnology, Pharmacy Practice, Pharmaceutics, Pharmaceutical Analysis, Medicinal Chemistry, Pharmaceutical Technology (Formulations), and Medical Devices - and supports a tier-2 Indian pharmaceutical education market with strong NIRF standing (12th in Pharmacy Category, 2025).

Its underlying infrastructure spans 10 Centres of Excellence, a NABL-accredited (ISO/IEC 17025:2017) Medical Device Testing and Calibration Facility, a CPCSEA-compliant central animal house with nude mice capability, a unique-in-NIPER Synthetic Biology Laboratory, and instrument-heavy platforms covering proteomics, pharmacokinetics, FTIR, GCMS, HPTLC, fluorescence spectroscopy, CHNS analysis, and 3D printing. Innovation operations are executed via two wholly-owned vehicles: the Bio-NEST Incubation Centre (Phase II backed by a Rs. 150 lakhs grant) and AIC NIPER-Guwahati Foundation, a Section 8 company incorporated in March 2022 under Atal Innovation Mission, NITI Aayog. The institute holds more than 40 MoUs including with Boehringer Ingelheim (2026), NUMALIGARH REFINERY LIMITED, AMTZ, CSIR-CCMB, CSIR-IICT, IIT Guwahati, ICT Mumbai, Fujifilm, and HAL, alongside participating in ASEAN-India academic exchanges.

Revenue mechanics are dominated by central government funding from the Department of Pharmaceuticals, supplemented by competitive research grants (DST, DBT, ICMR, CSIR, DHR, AYUSH, CCRAS, BIRAC, ANRF), tuition from domestic and international students (notably a 5% foreign nationals quota via the Study in India portal), industry-sponsored consultancy and testing revenue, and incubation centre fees/equity arrangements. Faculty credentials include six Stanford/Elsevier World Top 2% scientists (2024), an INAE Fellow Director, Royal Society of Biology and Telangana Academy Fellows, and MNASc members. The institute focuses on exploitation of natural and synthetic products from the North East for drug discovery and development, positioning its value proposition around being the regional anchor institution rather than a commercial player.

Name

National Institute of Pharmaceutical Education and Research Guwahati

Legal name

National Institute of Pharmaceutical Education and Research Guwahati

Website

https://niperguwahati.ac.in

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

NIPER Guwahati is a government-owned Institute of National Importance under India's Department of Pharmaceuticals, delivering postgraduate and doctoral pharmaceutical education and research across eight departments as the only national pharma institute for the North Eastern Region.

Ownership category

akta.pro rank

Product category

Pharmaceutical Education and Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYEDAHAGAE

Schools of Pharmacy

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAHAGAI

Biomedical Sciences & Medical Research Institutes (University-Based)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

Keywords

• Pharmaceutical education
• Pharmaceutical research
• Medical device testing
• Biotech incubation
• Drug discovery

Headquarters

HQ city

Guwahati

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

1. Government funding (Department of Pharmaceuticals): Core operational funding provided by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, as the institute is an autonomous body designated as an Institute of National Importance.
2. Student tuition and fees: Fee-based revenue from domestic and international postgraduate and doctoral students enrolled in MS(Pharm), M.Pharm, M.Tech, and PhD programmes.
3. Sponsored research grants: Funding received from government agencies including DST, DBT, ICMR, CSIR, DHR, AYUSH, CCRAS, BIRAC, ANRF for specific research projects.
4. Industry consultancy and testing services: Revenue from industry-academia collaborations, consulting services, and NABL-accredited medical device testing facility.
5. Incubation centre fees: Fees and equity arrangements from startups incubated at Bio-NEST and AIC NIPER-Guwahati Foundation Atal Incubation Centre.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

National Institute of Pharmaceutical Education and Research Guwahati (NIPER-G) is a government autonomous institute offering postgraduate and doctoral programs (MS Pharm, M.Pharm, M.Tech, PhD) across eight departments including Pharmacology & Toxicology, Biotechnology, Pharmacy Practice, Pharmaceutics, Pharmaceutical Analysis, Medicinal Chemistry, Pharmaceutical Technology (Formulations), and Medical Devices. It operates specialized research and service facilities including a NABL-accredited Medical Device Testing and Calibration Facility, Bio-NEST and Atal Incubation Centres for biotech startups, and conducts sponsored research and consultancy for the pharmaceutical industry.

Product overview

NIPER Guwahati is a premier national pharmaceutical education institute functioning under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. It offers a comprehensive portfolio of educational programs across pharmaceutical sciences, including MS (Pharm.), M.Pharm, M.Tech, and PhD programs through eight academic departments. The institute provides specialized research services through its NABL-accredited Medical Device Testing and Calibration Facility, supports innovation through Bio-NEST and Atal Incubation Centre, and serves as a Technical Resource Centre for evidence-based health research. The institution collaborates extensively with pharmaceutical industries and research organizations for drug discovery, development, and technology transfer.

Differentiator

Problem solved

Functional benefit

Products and services

• Academic Programs in Pharmaceutical Sciences Postgraduate and doctoral programs including MS (Pharm.), M.Pharm, M.Tech, and PhD across eight academic departments: Pharmacology & Toxicology, Biotechnology, Pharmacy Practice, Pharmaceutics, Pharmaceutical Analysis, Medicinal Chemistry, Pharmaceutical Technology (Formulations), and Medical Devices. Targets graduate-level students seeking careers in pharmaceutical sciences.
• Medical Device Testing and Calibration Facility NABL-accredited testing and calibration facility for medical devices, providing quality assessment and validation services for medical device manufacturers and researchers. Operated by the Medical Devices department.
• Bio-NEST Incubation Centre Bio-incubation centre supporting biotech and pharmaceutical startups with infrastructure, mentorship, and funding support. Received Rs. 150 lakhs grant for phase II expansion. Targets early-stage ventures in pharma and biotech.
• Atal Incubation Centre (AIC NIPER-Guwahati Foundation) Atal Incubation Centre established under Atal Innovation Mission, NITI Aayog, providing startup support, workspace, and innovation ecosystem for pharmaceutical and health-tech ventures through the AIC NIPER-Guwahati Foundation Section 8 company.
• Technical Resource Centre for Evidence-Based Guidelines Technical Resource Centre identified by the Department of Health Research (DHR), Ministry of Health & Family Welfare for conducting systematic reviews, meta-analyses, and evidence-based guidelines development. Operated by the Department of Pharmacy Practice.
• Institutional Biotech Hub (IBT-Hub)

Quantifiable outcome

• 12th rank in NIRF 2025 Pharmacy Category, up from 12th position acknowledged by Govt. of Assam
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

49 partnerships are on record, tiered major, core and minor.

• Boehringer IngelheimmajorStrategic or Co-development Partner · 20 February 2026Boehringer Ingelheim and NIPER Guwahati signed a memorandum of understanding (MoU) focused on pharmaceutical research collaboration. Details of scope, location, and strategic implications were not specified in the source.
• Growdea TechmajorTechnology or Integration · 27 January 2026A Technology Transfer Agreement (TTA) was executed between NIPER Guwahati and Growdea Tech for the development of accurate Phase II drug metabolism prediction technologies.
• AIC NIPER-Guwahati FoundationcoreStrategic or Co-development Partner · 26 September 2025Three separate MoUs signed with Dr. Sudarshana Borah, Ms. Monalisha Sengupta, and Dr. Pramod Kumar under the Atal Incubation Centre AIC NIPER-Guwahati Foundation.
• ICFRE-Rain Forest Research Institute, JorhatmajorStrategic or Co-development Partner · 16 April 2025MoU signed for collaboration in the fields of research, training, conservation, utilization and management of forest-based resources, capacity building, experience sharing and knowledge management and augmentation of natural resource based sustainable livelihood for the common people.
• Andhra Pradesh MedTech Zone (AMTZ)majorStrategic or Co-development Partner · 13 March 2025Strategic partnership to promote innovation in medical technology through the Innovation (iPassport) initiative. Aims to foster and give access to vibrant AMTZ ecosystem for MedTech innovation, entrepreneurship, and industry-academia partnerships for entrepreneurs of NIPER Guwahati.
• Central Council for Research in Ayurvedic Sciences (CCRAS)majorStrategic or Co-development Partner · 13 March 2025MoU signed for the project on 'Evolution of the anti-pyretic and anti-asthmatic activity of the ayurvedic formulations-Ayush GBP and Ayush CPP in experimental models'. Also collaborating on 'Development of Quality Standard of Elsholtzia Species and Assessment of Efficacy in Gastric Inflammatory Conditions' with RARC.
• NUMALIGARH REFINERY LIMITED (NRL)coreStrategic or Co-development Partner · 1 January 2025NRL-NIPER Guwahati Satellite Centre established as a novel approach to convert petroleum by-products to useful pharmaceuticals at NIPER Guwahati.
• IKP-PRIME, IKP Knowledge Park, HyderabadminorStrategic or Co-development Partner · 1 January 2025MoU signed with Dr. USN Murty, Director, NIPER-Guwahati for knowledge park collaboration and innovation support.
• Clean Green Biosystems, ChennaiminorStrategic or Co-development Partner · 28 August 2024MoU signed between Clean Green Biosystems (Dr. S.P. Mathi Maran, Founder Director & CEO) and ATAL INCUBATION CENTRE (AIC) NIPER-Guwahati Foundation.
• Regional Ayurveda Research Centre (RARC)minorStrategic or Co-development Partner · 22 July 2024MoU with RARC under Central Council of Research in Ayurveda Sciences, Ministry of Ayush, Govt. of India on collaborative project on 'Development of Quality Standard of Elsholtzia Species and Assessment of Efficacy in Gastric Inflammatory Conditions.'
• Fragrance & Flavour Development Centre (FFDC), KannaujminorStrategic or Co-development Partner · 8 May 2024MoU signed for Research Collaboration and Development of Flavour Lab for Food and Pharmaceuticals.
• Nalanda UniversityminorStrategic or Co-development Partner · 1 January 2024NIPER Guwahati signed an MoU with Nalanda University for ASEAN-India Network of Universities (AINU) Memorandum of Understanding for Faculty Exchange Programme.
• CIPET GuwahatiminorStrategic or Co-development Partner · 24 June 2022MoU signed with CIPET Guwahati for shared research facilities and academic collaboration.
• Tezpur UniversityminorStrategic or Co-development Partner · 1 February 2022MoU for academic and research collaboration.
• AIIMS GuwahatiminorStrategic or Co-development Partner · 1 January 2022MoU for collaborative research in pharmaceutical sciences and healthcare.
• Rajiv Gandhi UniversityminorStrategic or Co-development Partner · 15 November 2021MoU signed for academic and research collaboration.
• AIIMS Bibi NagarminorStrategic or Co-development Partner · 30 April 2021MoU for collaborative research in pharmaceutical sciences and healthcare.
• Institute of Bioresources and Sustainable Development (IBSD)minorStrategic or Co-development Partner · 8 April 2021MoU for collaborative research in bioresources and pharmaceutical sciences.
• Srimanta Sankaradeva Nethralaya, GuwahatiminorStrategic or Co-development Partner · 1 April 2021MoU for collaborative research in pharmaceutical sciences and ophthalmic healthcare.
• ASG Hospital, GuwahatiminorStrategic or Co-development Partner · 8 March 2021MoU for collaborative research in pharmaceutical sciences and healthcare.
• Hayat Hospital, GuwahatiminorStrategic or Co-development Partner · 5 March 2021MoU for collaborative research in pharmaceutical sciences and healthcare.
• AIIMS JodhpurminorStrategic or Co-development Partner · 5 March 2021MoU for collaborative research in pharmaceutical sciences and healthcare.
• Srijita Sen, Joyal Xavier, Nitesh Kumar (Research publications)minorOthers · 1 January 2021Collaborative research publications in exosomes as natural nanocarrier based drug delivery system (3 Biotech 2023).
• Daicel Chiral Technologies (India)minorImplementation/ SI/ Consulting Partner · 3 December 2020MoU for providing advisory consultancy on Chiral Chromatography to Daicel Customers in South East Asia.
• AMTZ VisakhapatnammajorStrategic or Co-development Partner · 7 October 2020MoU signed with Dr Jitendra Sharma, CMD AMTZ Visakhapatnam to organize the M.Tech (Medical Devices) program. Part of ongoing M.Tech Medical Devices programme collaboration.
• National Dope Testing Laboratory (NDTL), New DelhiminorStrategic or Co-development Partner · 17 July 2020MoU signed between Dr. USN Murty and Dr. P. L. Sahu, Scientific Director, NDTL Ministry of Youth Affairs & Sports, Govt. of India.
• Central Council for Research in Homeopathy (CCRH), New DelhiminorStrategic or Co-development Partner · 17 June 2020Collaboration between CCRH, New Delhi and NIPER Guwahati under Ministry of Chemicals and Fertilizers, Govt. of India.
• Hindustan Antibiotics Limited (HAL)minorStrategic or Co-development Partner · 20 May 2020Collaboration on novel coronavirus (COVID-19) research, addressing the pandemic of respiratory disease spreading from person-to-person.
• BVG Life Sciences Ltd. (BVG Group)minorStrategic or Co-development Partner · 6 July 2019MoU signed with Dr. Pawan K Singh, Vice President, BVG Life Sciences Ltd. at IASST for pharmaceutical research collaboration.
• Royal Global UniversityminorStrategic or Co-development Partner · 6 July 2019MoU signed with Ms. Angira Mimani, Registrar, Royal Global University, Guwahati at Institute of Advanced Study In Science and Technology (IASST).
• Innotech Interventions Pvt. LtdminorStrategic or Co-development Partner · 15 March 2019MoU signed with Sri Hamendra Ch. Das, CEO & Director, Innotech Interventions Pvt. Ltd at NIPER Guwahati.
• Institute of Liver and Biliary Sciences (ILBS), New DelhiminorStrategic or Co-development Partner · 4 January 2019MoU signed for mutual cooperation/collaborative research in areas of common interest.
• CSIR-CCMB, HyderabadmajorStrategic or Co-development Partner · 8 December 2018MoU signed with Dr. Rakesh Mishra, Director, CSIR CCMB for mutual cooperation and collaborative research in areas of common interests and related areas.
• FujifilmminorStrategic or Co-development Partner · 20 November 2018MoU signed with Dr. Lydia, Vice President, Fujifilm Europe and Asia for mutual cooperation and collaborative research in areas of common interest.
• Institute of Advanced Study in Science and Technology (IASST), GuwahatiminorStrategic or Co-development Partner · 25 August 2018MoU signed at NIPER Guwahati during National Conference on 'Ethno-Medicine and Traditional Health Practices in North East Region of India'.
• Dr. B Borooah Cancer InstituteminorStrategic or Co-development Partner · 9 June 2018MoU signed for mutual cooperation and collaborative research in areas of common interest with Dr. A. C. Kataki, Director.
• Mizoram University, AizawlminorStrategic or Co-development Partner · 19 May 2018MoU signed with K. R. S. Sambasiva Rao, Vice Chancellor, Mizoram University for mutual cooperation and collaborative research.
• IIT GuwahatimajorStrategic or Co-development Partner · 16 April 2018MoU signed with Prof. Gautam Biswas, Director, IIT Guwahati for mutual cooperation and collaborative research in areas of common interest.
• Dibrugarh UniversityminorStrategic or Co-development Partner · 2 April 2018MoU signed with Prof. Alak Kr. Buragohain, Vice Chancellor, Dibrugarh University for mutual cooperation in research and related areas.
• Assam Down Town UniversityminorStrategic or Co-development Partner · 28 December 2017MoU signed for mutual cooperation and collaborative research in areas of common interest of Pharmacology and related areas.
• CSIR-NEIST, JorhatmajorStrategic or Co-development Partner · 19 December 2017MoU signed with Dr. D. Ramaiah, Director, CSIR-NEIST for mutual cooperation and collaborative research.
• GNRC GuwahatiminorStrategic or Co-development Partner · 7 July 2017MoU signed for mutual cooperation and collaborative research in pharmaceutical sciences.
• Institute of Chemical Technology (ICT), MumbaiminorStrategic or Co-development Partner · 7 June 2017MoU entered with Institute of Chemical Technology, Mumbai for academic and research collaboration.
• Guwahati Biotech Park, IIT-Guwahati CampusmajorStrategic or Co-development Partner · 5 January 2017MoU signed for 2016 sqft lab space utilization at Guwahati Biotech Park for experimental work for students and faculty. Signed in presence of Chief Minister of Assam.
• UND Life Sciences, Ohio, USAminorStrategic or Co-development Partner · 5 January 2017MoU entered with UND Life Sciences for research collaboration. Dr. U.N. Das, Founder and President of UND Life Sciences participated in Guwahati Biotech Park MoU signing event.
• CSIR-National Physics Laboratory (NPL)minorStrategic or Co-development Partner · 1 January 2017MoU for collaborative research in pharmaceutical sciences.
• CSIR-Central Drug Research Institute (CDRI), LucknowmajorStrategic or Co-development Partner · 1 January 2017MoU for collaborative research in pharmaceutical sciences.
• CSIR-IICT, HyderabadmajorStrategic or Co-development Partner · 20 December 2016MoU signed for mutual cooperation and collaborative research in pharmaceutical sciences with CSIR-Indian Institute of Chemical Technology.
• NATCO PharmaminorStrategic or Co-development Partner · 18 November 2016MoU signed during Visitor's Conference at Rashtrapati Bhavan hosted by President Pranab Mukherjee.

Scale indicators9 records

Recent moves8 records

Expansion highlights7 records

Regional players

• IIT Guwahati: IIT Guwahati is the leading Indian Institute of Technology in Assam and a major MoU partner of NIPER Guwahati for collaborative research. It is comparable as the dominant regional academic institution with overlapping research infrastructure and faculty exchange opportunities.

Direct peers

• NIPER Mohali: NIPER Mohali was the first NIPER established in 1998 and offers the same postgraduate and doctoral pharmaceutical sciences programs under the Department of Pharmaceuticals. As a sister NIPER with identical mandate and regulatory designation, it is a closely comparable peer for academic and research benchmarking.
• JSS Academy of Higher Education & Research (Pharmacy): JSS College of Pharmacy is a top-ranked private pharmacy institution offering postgraduate and doctoral pharmaceutical programs. It is a comparable peer as a competing pharmaceutical education provider with strong research output and industry engagement.
• Institute of Chemical Technology (ICT) Mumbai: ICT Mumbai is a premier deemed university offering pharmaceutical sciences programs including M.Pharm and PhD, with a longstanding MoU partner of NIPER Guwahati. It is comparable as a top-tier Indian institute specializing in chemical and pharmaceutical technology education and research.
• NIPER Kolkata: NIPER Kolkata is a sister NIPER under the Department of Pharmaceuticals offering pharmaceutical education and research programs. The current Director of NIPER Guwahati holds additional charge at NIPER Kolkata, making it a tightly coupled peer institute.
• Manipal Academy of Higher Education (Pharmacy): Manipal College of Pharmacy is a leading private pharmacy institution in India offering M.Pharm and PhD programs with strong industry placement. It is comparable as a competing pharmaceutical education provider competing for similar postgraduate students and industry partnerships.
• NIPER Hyderabad: NIPER Hyderabad is the flagship and highest-ranked pharmaceutical education and research institute under the Department of Pharmaceuticals, operating the same NIPER model with MS(Pharm), M.Pharm, M.Tech, and PhD programs. It is the most direct comparable given shared governance, funding source, and academic structure.
• BITS Pilani (Pharmacy): BITS Pilani's Department of Pharmacy is a top-ranked private institution offering M.Pharm and PhD programs in pharmaceutical sciences. It is comparable as a competing institute with strong industry placement and a long-running research culture that competes with NIPER Guwahati for top students and faculty.

Broad incumbents

• CSIR-Central Drug Research Institute (CDRI): CSIR-CDRI is a national laboratory under the Council of Scientific and Industrial Research focused on drug discovery and pharmaceutical research. As an MoU partner of NIPER Guwahati, it represents a larger established peer in the same pharmaceutical R&D space.
• CSIR-Indian Institute of Chemical Technology (IICT): CSIR-IICT Hyderabad is a large national research institute conducting pharmaceutical and chemical technology research. As an MoU partner of NIPER Guwahati, it is a comparable larger established player with overlapping research and training scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=Q5ARB50wrEg
• Xx.com/GuwahatiNiper
• Facebookfacebook.com/NIPERG
• LinkedInlinkedin.com/company/niperg

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute of Pharmaceutical Education and Research Guwahati